SOSS Complex as Drug Target and Biomarker (P16362)

Target Name: SOSS complex

NCBI ID: P16362

SOSS complex

Other Name(s): None

SOSS Complex as Drug Target and Biomarker

The SOSS complex, or solute carrier system, is a protein structure in the endoplasmic reticulum (ER) that is responsible for transporting various substances throughout the cell. It is made up of a network of transmembrane proteins that form a complex structure and are involved in the delivery of a wide variety of molecules, including drugs and other signaling molecules.

Recent studies have identified SOSS complex as a drug target and a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because the SOSS complex plays a key role in the delivery of many of these molecules and is involved in the regulation of their levels within the cell.

One of the key functions of the SOSS complex is its role in the delivery of drugs. Many drugs work by interacting with specific proteins within the SOSS complex and disrupting their function. This can lead to the inhibition of signaling pathways and the inhibition of cell growth and proliferation.

For example, the SOSS complex is involved in the delivery of the drug doxorubicin, which is used to treat various types of cancer. doxorubicin works by inhibiting the activity of the protein heat shock protein (HSP70), which is a key component of the SOSS complex. This inhibition of HSP70 leads to the accumulation of doxorubicin within cells, where it can cause DNA damage and cell death.

Another example of a drug that works by interacting with the SOSS complex is the neurodegenerative disease drug spatulate. spatulate is a drug that is used to treat Alzheimer's disease and other forms of dementia. It works by interacting with the protein Tau, which is a key component of the SOSS complex. This interaction leads to the inhibition of the activity of Tau, which is believed to contribute to the progression of neurodegenerative diseases.

In addition to its role in drug delivery, the SOSS complex is also involved in the regulation of the levels of many other molecules within the cell. For example, it is involved in the delivery of proteins involved in cell signaling pathways, such as insulin and growth factors. It is also involved in the delivery of proteins involved in cell adhesion and migration, such as cadherins and integrins.

The SOSS complex is also involved in the regulation of the levels of many signaling molecules within the cell. For example, it is involved in the delivery of the protein p53, which is a key regulator of the DNA damage response. p53 is often used as a drug target in cancer because its activity is disrupted by many drugs, including those that are used to treat cancer.

In conclusion, the SOSS complex is a protein structure that plays a critical role in the delivery of many different molecules within the cell. Its involvement in drug delivery and the regulation of the levels of many signaling molecules makes it an attractive target for the development of new drugs for a variety of diseases. Further research is needed to fully understand the functions of the SOSS complex and its potential as a drug target.

Protein Name: SOSS Complex

The "SOSS complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOSS complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets